Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ ...
The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.
New research reveals how Parkinson's spreads from the gut to the brain, with the help of immune cells—offering a new ...
Competition funded by Citadel founder and CEO Ken Griffin spurred a scientific race to develop an imaging tracer to visualize the key protein alpha-synuclein in the living brains of people with ...
After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, ...
Researchers visualize alpha-synuclein pathology in living patients with a neurodegenerative disorder
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of alpha-synuclein in the brain. Now, scientists have developed a radioligand that facilitates the ...
More than a decade has passed since researchers led by Dennis Selkoe of Brigham and Women’s Hospital in Boston first reported that when α-synuclein has its druthers, it prefers the company of three ...
The so-called isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance. A research team headed by Professor Dr Erdem Gültekin Tamgüney ...
A research team led by Associate Professor Ayako Okado-Matsumoto from the Department of Biology at Toho University has made a significant finding that sheds new light on Dementia with Lewy Bodies (DLB ...
Phosphorylation of α-synuclein at serine 129 has long been used as a marker of synucleinopathy—p-S129syn accumulates in Lewy bodies, after all. But does this modification have a physiological function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results